These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2498523)

  • 1. Chemoprevention strategies utilizing combinations of inhibitors of carcinogenesis.
    Malone WF; Kelloff GJ
    J Natl Cancer Inst; 1989 Jun; 81(11):824. PubMed ID: 2498523
    [No Abstract]   [Full Text] [Related]  

  • 2. New approaches to cancer chemoprevention with difluoromethylornithine and selenite.
    Ip C; Thompson HJ
    J Natl Cancer Inst; 1989 Jun; 81(11):839-43. PubMed ID: 2498524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difluoromethylornithine in cancer: new advances.
    Alexiou GA; Lianos GD; Ragos V; Galani V; Kyritsis AP
    Future Oncol; 2017 Apr; 13(9):809-819. PubMed ID: 28125906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of mammary carcinogenesis: a comparative review of the efficacy of a polyamine antimetabolite, retinoids, and selenium.
    Thompson HJ; Herbst EJ; Meeker LD
    J Natl Cancer Inst; 1986 Sep; 77(3):595-8. PubMed ID: 3091894
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions.
    Ip C; White G
    Carcinogenesis; 1987 Dec; 8(12):1763-6. PubMed ID: 3119243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemoprevention.
    Griffin AC
    J Cancer Res Clin Oncol; 1980; 98(1):1-7. PubMed ID: 7005246
    [No Abstract]   [Full Text] [Related]  

  • 8. The chemopreventive role of selenium in carcinogenesis.
    Ip C
    Adv Exp Med Biol; 1986; 206():431-47. PubMed ID: 3591532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
    Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
    Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.
    Meyskens FL; Simoneau AR; Gerner EW
    Recent Results Cancer Res; 2014; 202():115-20. PubMed ID: 24531785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of human skin cancers.
    Loescher LJ; Meyskens FL
    Semin Oncol Nurs; 1991 Feb; 7(1):45-52. PubMed ID: 2011658
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents.
    Reddy BS
    Adv Exp Med Biol; 1997; 400B():931-6. PubMed ID: 9547649
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemoprevention: future direction of colorectal cancer prevention.
    Zhou P; Cheng SW; Yang R; Wang B; Liu J
    Eur J Cancer Prev; 2012 May; 21(3):231-40. PubMed ID: 22456425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
    Chang SS
    J Urol; 2015 May; 193(5):1727. PubMed ID: 25895810
    [No Abstract]   [Full Text] [Related]  

  • 17. Selenium and colon cancer--from chemoprevention to new treatment modality.
    Rudolf E; Králová V; Cervinka M
    Anticancer Agents Med Chem; 2008 Aug; 8(6):598-602. PubMed ID: 18690824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does selenium reduce the cancer risk in man?].
    Voigtmann R
    Dtsch Med Wochenschr; 1989 Apr; 114(15):573-4. PubMed ID: 2702934
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
    Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
    Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous and exogenous polyamines in support of tumor growth.
    Seiler N; Sarhan S; Grauffel C; Jones R; Knödgen B; Moulinoux JP
    Cancer Res; 1990 Aug; 50(16):5077-83. PubMed ID: 2116224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.